FosterNC, BeckRW, MillerKM, et al.State of type 1 diabetes management and outcomes from the T1D Exchange in 2016-2018. Diabetes Technol Ther, 2019; 21: 66–72.
2.
SherrJL, HermannJM, CampbellF, et al.T1D Exchange Clinic Network, the DPV Initiative, and the National Pediatric Diabetes Audit and the Royal College of Pediatrics and Child Health registries. Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: Comparison of results from three large, transatlantic pediatric registries. Diabetologia, 2016; 59: 87–91.
3.
DeSalvoDJ, MillerKM, HermannJM, et al.Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative. Pediatr Diabetes, 2018; 19: 1271–1275.
4.
SzypowskaA, SchwandtA, SvenssonJ, et al.Insulin pump therapy in children with type 1 diabetes: Analysis of data from the SWEET registry. Pediatr Diabetes, 2016; 17(Suppl 23): 38–45.
5.
van den BoomL, KargesB, AuzanneauM, et al.Temporal trends and contemporary use of insulin pump therapy and glucose monitoring among children, adolescents, and adults with type 1 diabetes between 1995 and 2017. Diabetes Care, 2019; 42: 2050–2056.
6.
MillerKM, HermannJ, FosterN, et al.Longitudinal changes in continuous glucose monitoring use among individuals with type 1 diabetes: International comparison in the German and Austrian DPV and U.S. T1D Exchange registries. Diabetes Care, 2020; 43: e1–e2
7.
OlsenB, JohannesenJ, FredheimS, et al.Danish Society for Childhood and Adolescent Diabetes. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes. Pediatr Diabetes, 2015; 16: 256–262.
8.
ŠumníkZ, SzypowskaA, IotovaV, et al.Persistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: The SWEET perspective. Pediatr Diabetes, 2019; 20: 434–443.
9.
SherrJL, TauschmannM, BattelinoT, et al.ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies. Pediatr Diabetes, 2018; 19(Suppl 27): 302–325.
10.
KargesB, SchwandtA, HeidtmannB, et al.Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes. JAMA, 2017; 318: 1358–1366.
11.
TauschmannM, HermannJM, FreibergC, et al.Reduction in diabetic ketoacidosis and severe hypoglycemia in pediatric type 1 diabetes during the first year of continuous glucose monitoring: A multicenter analysis of 3,553 subjects from the DPV registry. Diabetes Care, 2020; 43: e40–e42.
12.
Moreno-FernandezJ, GomezFV, GazquezM, et al.Real-time continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: Results of a pilot study. Diabetes Technol Ther, 2013; 15: 596–600.
13.
BergenstalRM, TamborlaneWV, AhmannA, et al.Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med, 2010; 363: 311–320.
14.
RashotteJ, TousignantK, RichardsonC, et al.Living with sensor augmented pump therapy in type 1 diabetes: Adolescents' and parents' search for harmony. Can J Diabetes, 2014; 38: 256–262.
15.
PattonS, ClementsM. Psychological reactions associated with continuous glucose monitoring in youth. J Diabetes Sci Technol, 2016; 10: 656–661.
16.
CampbellFM, MurphyNP, StewartC, BiesterT, KordonouriO. Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study. Pediatr Diabetes, 2018; 19: 1294–1301.
17.
HalbronM, BourronO, AndreelliF, et al.Insulin pump combined with flash glucose monitoring: A therapeutic option to improve glycemic control in severely non-adherent patients with type 1 diabetes. Diabetes Technol Ther, 2019; 21: 409–412.
18.
LandauZ, AbiriS, GruberN, et al.Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience. Acta Diabetol, 2018; 55: 1303–1310.
19.
DeshmukhH, WilmotEG, GregoryR, et al.Effect of flash glucose monitoring on glycemic control, hypoglycemia, diabetes-related distress, and resource utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit. Diabetes Care, 2020; 43: 2153–2160.
20.
JangamS, DunnT, XuY, HayterG, AjjanRA. Flash glucose monitoring improves glycemia in higher risk patients: A longitudinal, observational study under real-life settings. BMJ Open Diabetes Res Care, 2019; 7: e000611.
21.
ChenE, KingF, KohnMA, SpanakisEK, BretonM, KlonoffDC. A review of predictive low glucose suspend and its effectiveness in preventing nocturnal hypoglycemia. Diabetes Technol Ther, 2019; 21: 602–609.
22.
MaahsDM, CalhounP, BuckinghamBA, et al.A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes. Diabetes Care, 2014; 37: 1885–1891.
23.
BuckinghamBA, RaghinaruD, CameronF, et al.Predictive low-glucose insulin suspension reduces duration of nocturnal hypoglycemia in children without increasing ketosis. Diabetes Care, 2015; 38: 1197–1204.
24.
WeismanA, BaiJW, CardinezM, KramerCK, PerkinsBA. Effect of artificial pancreas systems on glycemic control in patients with type 1 diabetes: A systematic review and meta-analysis of outpatient randomized controlled trials. Lancet Diabetes Endocrinol, 2017; 5: 501–512.
25.
BrownSA, KovatchevBP, RaghinaruD, et al.Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med, 2019; 381: 1707–1717.
26.
BretonMD, KanapkaLG, BeckRW, et al.A randomized trial of closed-loop control in children with type 1 diabetes. N Engl J Med, 2020; 383: 836–845.
27.
GargSK, WeinzimerSA, TamborlaneWV, et al.Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther, 2017; 19: 55–163.
28.
BergetC, MesserLH, VigersT, et al.Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670G system. Pediatr Diabetes, 2020; 21: 310–318.
29.
MesserLH, BergetC, VigersT, et al.Real world hybrid closed-loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months. Pediatr Diabetes, 2020; 21: 319–327.
30.
ShalitinS, Ben-AriT, Yackobovitch-GavanM, et al.Using the internet-based upload blood glucose monitoring and therapy management system in patients with type 1 diabetes. Acta Diabetol, 2014; 51: 247–256.
31.
BeckR. W. Downloading diabetes device data: Empowering patients to download at home to achieve better outcomes. Diabetes Technol Ther, 2015; 17: 536–537.
